deltatrials
Terminated PHASE2 INTERVENTIONAL NCT00043459

Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma.

Sponsor: Tularik

Conditions Non-Hodgkin's Lymphoma
Interventions intravenous T900607-sodium
Updated 5 times since 2017 Last updated: Jun 23, 2005 Started: Jul 31, 2002 Completion: Mar 31, 2003
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Tularik

More terminations from Tularik

Other Non-Hodgkin's Lymphoma trials with similar outcome

Browse all Non-Hodgkin's Lymphoma trials

A PHASE2 clinical study on Non-Hodgkin's Lymphoma, this trial is terminated or withdrawn. The trial is conducted by Tularik and has accumulated 5 data snapshots since 2002. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 23 months · monthly snapshotTerminated

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE2

    First recorded

Jul 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Tularik
Data source: Tularik

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations